20.56
-0.25(-1.20%)
Currency In USD
| Previous Close | 20.56 |
| Open | 19.97 |
| Day High | 20 |
| Day Low | 19.13 |
| 52-Week High | 29.16 |
| 52-Week Low | 19.02 |
| Volume | 319,324 |
| Average Volume | 893,800 |
| Market Cap | 1.04B |
| PE | -17.03 |
| EPS | -1.16 |
| Moving Average 50 Days | 21.1 |
| Moving Average 200 Days | 21.1 |
| Change | -0.81 |
If you invested $1000 in Akoustis Technologies, Inc. (AKTS) 10 years ago, it would be worth $12,094.12 as of January 19, 2026 at a share price of $20.56. Whereas If you bought $1000 worth of Akoustis Technologies, Inc. (AKTS) shares 5 years ago, it would be worth $1,427.78 as of January 19, 2026 at a share price of $20.56.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire Inc.
Jan 13, 2026 11:30 AM GMT
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
GlobeNewswire Inc.
Dec 16, 2024 6:22 AM GMT
Committed to Full Continuity in Delivering Next-Generation BAW High-Band RF Filters to Customers Around the World Filing to Ensure Business Sold Free and Clear of Qorvo Infringement Following Final Judgement and Required Cleansing ProcessCharlotte,